Lumentum Executive's $1.87M Sale Follows $2.6M in Recent Transactions
Rhea-AI Filing Summary
Lumentum Holdings Director Alan S. Lowe has filed a Form 144 indicating intent to sell 20,000 shares of common stock with an aggregate market value of $1,869,400. The planned sale is scheduled for June 26, 2025, through Morgan Stanley Smith Barney on NASDAQ.
The shares to be sold were acquired through multiple transactions between August 2022 and February 2023, including:
- Restricted Stock grants totaling 5,824 shares
- Performance Share awards totaling 14,176 shares
Notable recent trading activity shows Lowe has sold 30,000 shares in the past three months for total gross proceeds of approximately $2.6 million. The filing indicates Lowe is trading under a 10b5-1 plan adopted on November 20, 2024, and affirms no knowledge of undisclosed material adverse information regarding Lumentum's operations.
Positive
- None.
Negative
- CEO Alan Lowe has sold approximately 50,000 shares worth over $4.4M in the past month through multiple transactions, including a planned sale of 20,000 additional shares worth $1.87M, signaling significant insider selling pressure